The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Novel nuclear cardiac system nears market
October 26th 2007Next month Spectrum Dynamics will begin shipping its long-awaited D-SPECT Cardiac imaging product, featuring solid-state cadmium-zinc-telluride detectors and proprietary image reconstruction techniques that cut the time typically needed to do a SPECT heart scan by 75% or more. The Danville, CA-based company will target high-volume private cardiac labs and hospitals that put a premium on throughput and image quality.
Philips CFO deflects questions about RSNA unveilings
October 23rd 2007Digesting the mediocre performance by Philips Medical in the third quarter, financial analysts peppered Pierre-Jean Sivignon, chief financial officer of Koninklijke Philips Electronics, with questions about the company’s plans for the upcoming RSNA. They were looking for reasons to believe the CFO’s assertions that Philips’ financials would soon improve.
RadNet purchase paves way to strategic opportunities
October 23rd 2007The Deficit Reduction Act has undercut reimbursements for outpatient centers, ripening the market for consolidation -- and RadNet has been harvesting. The company last week acquired Liberty Pacific MRI of Encino for $2.8 million, the fourth California imaging center RadNet has bought in little more than a month.
Three-D measure of metabolism uses FDG to track response to mesothelioma therapy
October 18th 2007Patients with mesothelioma, a disease of the lung lining caused by exposure to asbestos, may someday benefit from a new 3D PET measure that helps accurately and quickly measure response to chemotherapy, according to a study published in the Journal of Nuclear Medicine.
Coronary CT angiography saves lives and money: 20,000-plus cases prove it
Questions remain from practitioners, payers, and administrators regarding the economic impact of coronary CT angiography on established diagnostic modalities and the effects on reimbursement within imaging. To address these concerns, we have developed the CCTA Data Registry, which now consists of more than 20,000 cases. Preliminary results indicate that coronary CTA is being utilized appropriately and affects savings for the healthcare system.
Vendor emphasizes performance, flexible pricing of gamma cameras
October 1st 2007This year, the first sites in the world will begin using Philips Medical Systems' newly minted BrightView family of gamma cameras. The compact dual-head product shines at the high end of the company's nuclear medicine portfolio in performance and versatility. But it need not be the most powerful gamma camera in the hospital or clinic.
NAS report recommends renewed federal leadership in nuclear medicine science
September 24th 2007A blue ribbon panel convened by the National Academies of Science recommends after a year of hearings and deliberations that the U.S. government recommit itself to the advancement of nuclear medicine science.
PET study finds connection between chemistry, behavior
September 1st 2007One of the most interesting topics in science today is the relationship between the mind and the brain. Its study is being propelled particularly by the use of nuclear medicine imaging, and this theme was echoed throughout the 2007 SNM meeting.
Split-bolus CT urography technique cuts radiation dose
August 30th 2007Vendors have employed a multitude of approaches to cut patient radiation dose by making data acquisition and analysis more efficient. Software has been developed to adjust dose to fit different body types and segments. Methods to factor in body weight, particularly when scanning children, have been considered. Step-and-shoot protocols have been devised to eliminate the overlap that comes from spiral scanning.
MR, nuclear medicine show advantages over mammography
August 14th 2007Competitors to x-ray mammography may be mounting a serious challenge to the long-standing technology. Research has determined that MR and nuclear medicine can detect ductal carcinoma in situ (DCIS), which can develop into an invasive form of breast cancer, much earlier than mammography can.
DRA crushes demand for big-ticket scanners
August 1st 2007Big-ticket items are suffering this year as reimbursement cuts resulting from the Deficit Reduction Act have had a wider and longer lasting effect than initially expected. Particularly hard hit has been PET/CT. The hybrid juggernaut had defied the odds for several years, marching forward with ever higher sales despite utilization rates at individual sites that allowed plenty of unused capacity.
Molecular imaging steers specialty to personalized care
August 1st 2007The growing field of molecular imaging is helping nuclear medicine physicians identify pathways into personalized patient care. This overall assessment informed Dr. Henry Wagner's 30th annual highlights lecture at the 2007 Society of Nuclear Medicine meeting held in June in Washington, DC. Neuroimaging seems set to become the next new thing.
Nuclear medicine gains traction from PET/CT, new radioisotopes
August 1st 2007Rapid technological developments, in terms of both instrumentation and radiopharmaceuticals, are making nuclear medicine an increasingly relevant part of daily clinical practice, according to Prof. Peter Ell, director of the Institute of Nuclear Medicine at University College London.&qu
Whole-body imaging brings new slant to cancer staging
August 1st 2007Radiologist interest in whole-body diffusion-weighted MRI for cancer applications is intensifying following preliminary studies that demonstrate its potential value for staging cancer. Whole-body DWI produces a composite image using a STIR echo-planar diffusion-weighted technique with a high b-value for background suppression.
Fusion software improves CT, SPECT cardiovascular scans
August 1st 2007Using special software to fuse myocardial perfusion SPECT and CT angiography data acquired on separate scanners could be a cost-effective alternative for the diagnosis of patients with suspected myocardial disease, according to two studies presented at the 2007 Society of Nuclear Medicine meeting.